Background
Two cases of conjunctival carcinoma developed orbital invasion during treatment with topical medication.
Methods
This was a retrospective study from a tertiary ophthalmic oncology unit, performed after informed consent was obtained. The
main outcome measurement was orbital invasion.
Results
Two patients treated with topical agents developed orbital invasion.
Conclusion
While topical agents are important in treatment of conjunctival neoplasia, recurrence or deep invasion require careful monitoring.
Keywords Orbital invasion - Squamous cell carcinoma - Mitomycin - Topical medication
Supported in part by a grant from the Tumori Foundation. The author has no financial interest in the subject matter.